{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:15:38Z","timestamp":1791573338363,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CPP2021-008557"],"award-info":[{"award-number":["CPP2021-008557"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-114753RB-I00"],"award-info":[{"award-number":["PID2020-114753RB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.biopha.2023.114715","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T13:03:12Z","timestamp":1681736592000},"page":"114715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["VCE-005.1, an hypoxia mimetic betulinic acid derivative, induces angiogenesis and shows efficacy in a murine model of traumatic brain injury"],"prefix":"10.1016","volume":"162","author":[{"given":"Mar\u00eda Eugenia","family":"Prados","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1438-9216","authenticated-orcid":false,"given":"Carmen","family":"Navarrete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela","family":"Garc\u00eda-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Lastres-Cubillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Ponce-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Mart\u00ednez-Orgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8478-5842","authenticated-orcid":false,"given":"Eduardo","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.114715_bib1","first-page":"1","article-title":"Estimating the global incidence of traumatic brain injury","author":"Dewan","year":"2018","journal-title":"J. Neurosurg."},{"issue":"7","key":"10.1016\/j.biopha.2023.114715_bib2","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1177\/0963689717714102","article-title":"Traumatic brain injury: current treatment strategies and future endeavors","volume":"26","author":"Galgano","year":"2017","journal-title":"Cell Transpl."},{"key":"10.1016\/j.biopha.2023.114715_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/biomedicines8100389","article-title":"Revisiting traumatic brain injury: from molecular mechanisms to therapeutic interventions","volume":"8","author":"Jarrahi","year":"2020","journal-title":"Biomedicines"},{"issue":"44","key":"10.1016\/j.biopha.2023.114715_bib4","doi-asserted-by":"crossref","first-page":"27667","DOI":"10.1073\/pnas.2010430117","article-title":"P7C3-A20 treatment one year after TBI in mice repairs the blood-brain barrier, arrests chronic neurodegeneration, and restores cognition","volume":"117","author":"Vazquez-Rosa","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.biopha.2023.114715_bib5","first-page":"1147","article-title":"Blood-brain barrier disruption is an early event that may persist for many years after traumatic brain injury in humans","volume":"74","author":"Hay","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.biopha.2023.114715_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","article-title":"The blood-brain barrier in Alzheimer's disease","volume":"107","author":"Zenaro","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"21","key":"10.1016\/j.biopha.2023.114715_bib7","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1111\/febs.13412","article-title":"The dynamic blood-brain barrier","volume":"282","author":"Keaney","year":"2015","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.biopha.2023.114715_bib8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.immuni.2014.09.008","article-title":"HIF transcription factors, inflammation, and immunity","volume":"41","author":"Palazon","year":"2014","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biopha.2023.114715_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12929-020-00658-7","article-title":"Pathophysiological implications of hypoxia in human diseases","volume":"27","author":"Chen","year":"2020","journal-title":"J. Biomed. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2023.114715_bib10","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1161\/01.STR.0000166180.91042.02","article-title":"Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin","volume":"36","author":"Liu","year":"2005","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.biopha.2023.114715_bib11","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1530\/REM-22-0011","article-title":"Hypoxic preconditioning induces neuroprotection against oxidative stress","volume":"2022","author":"Mill\u00e1n","year":"2022","journal-title":"Redox Exp. Med."},{"key":"10.1016\/j.biopha.2023.114715_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fcell.2018.00175","article-title":"Hypoxia mimetic agents for ischemic stroke","volume":"6","author":"Davis","year":"2018","journal-title":"Front Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114715_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5607\/en.2013.22.1.1","article-title":"Multi target neuroprotective and neurorestorative anti-Parkinson and anti-Alzheimer drugs ladostigil and m30 derived from rasagiline","volume":"22","author":"Youdim","year":"2013","journal-title":"Exp. Neurobiol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114715_bib14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/jcbfm.2010.60","article-title":"Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats","volume":"31","author":"Nagel","year":"2011","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2023.114715_bib15","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s13311-021-01089-4","article-title":"Betulinic acid hydroxamate is neuroprotective and induces protein phosphatase 2A-dependent HIF-1alpha stabilization and post-transcriptional dephosphorylation of prolyl hydrolase 2","volume":"18","author":"Prados","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"7","key":"10.1016\/j.biopha.2023.114715_bib16","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/s41401-020-0497-0","article-title":"Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel disease","volume":"42","author":"Prados","year":"2021","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2023.114715_bib17","article-title":"Neuroprotective efficacy of betulinic acid hydroxamate, a B55alpha\/PP2A activator, in acute hypoxia-ischemia-induced brain damage in newborn rats","author":"Silva","year":"2022","journal-title":"Transl. Stroke Res"},{"issue":"24","key":"10.1016\/j.biopha.2023.114715_bib18","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.3390\/nu14245286","article-title":"Neuroprotective effects of betulinic acid hydroxamate in intraventricular hemorrhage-induced brain damage in immature rats","volume":"14","author":"Del Pozo","year":"2022","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.biopha.2023.114715_bib19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/CIRCRESAHA.119.316071","article-title":"B55alpha\/PP2A limits endothelial cell apoptosis during vascular remodeling: a complementary approach to disrupt pathological vessels?","volume":"127","author":"Ehling","year":"2020","journal-title":"Circ. Res"},{"issue":"7","key":"10.1016\/j.biopha.2023.114715_bib20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/1873-3468.12907","article-title":"Protein phosphatase 2A and tau: an orchestrated 'Pas de Deux'","volume":"592","author":"Taleski","year":"2018","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.biopha.2023.114715_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12974-022-02540-9","article-title":"A cannabidiol aminoquinone derivative activates the PP2A\/B55alpha\/HIF pathway and shows protective effects in a murine model of traumatic brain injury","volume":"19","author":"Navarrete","year":"2022","journal-title":"J. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.biopha.2023.114715_bib22","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1021\/acs.jnatprod.8b00514","article-title":"Triterpenoid Hydroxamates as HIF Prolyl Hydrolase Inhibitors","volume":"81","author":"Minassi","year":"2018","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2023.114715_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neulet.2017.03.001","article-title":"Protective effects of angiopoietin-like 4 on the blood-brain barrier in acute ischemic stroke treated with thrombolysis in mice","volume":"645","author":"Zhang","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.biopha.2023.114715_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10048-019-00587-0","article-title":"Nervous NDRGs: the N-myc downstream-regulated gene family in the central and peripheral nervous system","volume":"20","author":"Schonkeren","year":"2019","journal-title":"Neurogenetics"},{"issue":"3","key":"10.1016\/j.biopha.2023.114715_bib25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.31083\/j.jin.2020.03.4","article-title":"The effects of erythropoietin on neurogenesis after ischemic stroke","volume":"19","author":"Zhang","year":"2020","journal-title":"J. Integr. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2023.114715_bib26","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s12035-015-9672-6","article-title":"Glucose transporters at the blood-brain barrier: function, regulation and gateways for drug delivery","volume":"54","author":"Patching","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114715_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12987-019-0123-z","article-title":"Claudin-5: gatekeeper of neurological function","volume":"16","author":"Greene","year":"2019","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"10.1016\/j.biopha.2023.114715_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(97)00239-5","article-title":"The biphasic opening of the blood-brain barrier in the cortex and hippocampus after traumatic brain injury in rats","volume":"226","author":"Baskaya","year":"1997","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.biopha.2023.114715_bib29","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1177\/0271678X17701460","article-title":"Response of the cerebral vasculature following traumatic brain injury","volume":"37","author":"Salehi","year":"2017","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"5","key":"10.1016\/j.biopha.2023.114715_bib30","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1189\/jlb.3RU0816-352RR","article-title":"Endothelial cell activation in central nervous system inflammation","volume":"101","author":"Wu","year":"2017","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114715_bib31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/bja\/aem131","article-title":"Pathophysiology of traumatic brain injury","volume":"99","author":"Werner","year":"2007","journal-title":"Br. J. Anaesth."},{"issue":"1","key":"10.1016\/j.biopha.2023.114715_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40635-015-0039-0","article-title":"Shape descriptors of the \"never resting\" microglia in three different acute brain injury models in mice","volume":"3","author":"Zanier","year":"2015","journal-title":"Intensive Care Med Exp."},{"issue":"12","key":"10.1016\/j.biopha.2023.114715_bib33","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.15252\/embr.201541499","article-title":"Central CCL2 signaling onto MCH neurons mediates metabolic and behavioral adaptation to inflammation","volume":"17","author":"Le Thuc","year":"2016","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.biopha.2023.114715_bib34","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s12974-020-02036-4","article-title":"CCL2 is associated with microglia and macrophage recruitment in chronic traumatic encephalopathy","volume":"17","author":"Cherry","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2023.114715_bib35","doi-asserted-by":"crossref","unstructured":"Chen, Y., et al., Multiplex Assessment of Serum Chemokines CCL2, CCL5, CXCL1, CXCL10, and CXCL13 Following Traumatic Brain Injury. Inflammation, 2022.","DOI":"10.1007\/s10753-022-01729-7"},{"issue":"10","key":"10.1016\/j.biopha.2023.114715_bib36","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1080\/17425255.2021.1991308","article-title":"AMPK activators for the prevention and treatment of neurodegenerative diseases","volume":"17","author":"Neumann","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.biopha.2023.114715_bib37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/ijms21072428","article-title":"Activation of AMPK under hypoxia: many roads leading to Rome","volume":"21","author":"Dengler","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.biopha.2023.114715_bib38","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1080\/15384101.2015.1055426","article-title":"AMPK-HDAC5 pathway facilitates nuclear accumulation of HIF-1alpha and functional activation of HIF-1 by deacetylating Hsp70 in the cytosol","volume":"14","author":"Chen","year":"2015","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.biopha.2023.114715_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033433","article-title":"Inhibition of SIRT1 impairs the accumulation and transcriptional activity of HIF-1alpha protein under hypoxic conditions","volume":"7","author":"Laemmle","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2023.114715_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/jnc.13726","article-title":"Traumatic brain injury decreases AMP-activated protein kinase activity and pharmacological enhancement of its activity improves cognitive outcome","volume":"139","author":"Hill","year":"2016","journal-title":"J. Neurochem"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223005036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223005036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:44:10Z","timestamp":1778247850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223005036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":40,"alternative-id":["S0753332223005036"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114715","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VCE-005.1, an hypoxia mimetic betulinic acid derivative, induces angiogenesis and shows efficacy in a murine model of traumatic brain injury","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114715"}}